ESC 365 - Hemodynamic and anti-remodelling effect of the rho kinase inhibitor y-27632 in monocrotaline pulmonary arterial hypertension rat model

ESC Premium Access

Hemodynamic and anti-remodelling effect of the rho kinase inhibitor y-27632 in monocrotaline pulmonary arterial hypertension rat model

Session: Basic mechanisms in pulmonary hypertension

Topic: Chronic pulmonary hypertension

Speaker: Doctor S. Cantoni (Parma, IT)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Silvia Cantoni

R&D Chiesi Farmaceutici S.P.A., Parma (Italy)

0 follower

6 more presentations in this session

A new experimental model of pulmonary arterial hypertension- KDR knock out

Speaker: Doctor M. Winter (Vienna, AT)

Hypoxia induces the downregulation of the BMP signalling in pulmonary artery smooth muscle cells through the endothelin system

Speaker: Doctor H. Maruyama (Tsuchiura, JP)

Preventive effects of novel urotensin II receptor antagonist in experimental pulmonary arterial hypertension

Speaker: Doctor B. Lee (Daejeon, KR)

Hypoxia-induced pulmonary hypertension is attenuated by hypoxia-inducible factor-1 alpha deletion in macrophage

Speaker: Mr H. Kojima (Fukuoka, JP)

Levosimendan prevents and reverts pressure-overload induced right ventricular failure.

Speaker: Miss M. Hansen (Aarhus, DK)

Access the full session

Basic mechanisms in pulmonary hypertension

Speakers: Doctor S. Cantoni, Doctor M. Winter, Doctor H. Maruyama, Doctor B. Lee, Mr H. Kojima...

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources